How often do you take Mounjaro for weight loss?

Your pen has arrived, and the dose printed on it feels lower than you expected

A lot of people open their first Mounjaro pen, see 2.5 mg, and assume there has been a mistake. There has not. Every prescriber starts patients here for a specific reason: at this level, most people's digestive systems can settle into the medicine without significant nausea. The 2.5 mg starting dose is not trying to produce weight loss directly, it is giving your body a four-week runway before the therapeutic work begins in earnest.

After roughly four weeks on 2.5 mg, your prescriber will typically move you to 5 mg, then 7.5 mg, and so on, but the pace is individual. If one step is causing difficult side effects, your clinician may recommend staying at the current dose for another cycle rather than pushing forward. Nothing in the schedule is automatic. Each pen is once a week; the path through the doses is guided by how you are tolerating treatment.

Pick a day that suits your routine (Sunday evenings, Wednesday mornings) and keep it consistent. Mounjaro does not require a fasted state or a specific time of day, which makes it easier to build into real life. Our Mounjaro page covers the full picture if you want to understand the medicine before starting.

What 'once a week' actually means when life gets in the way

The weekly schedule sounds simple until a busy week arrives. The most practical guidance is this: inject on your chosen day whenever possible. If you miss it, the NHS tirzepatide page and the Patient Information Leaflet are the right places to check exactly what to do, general advice for missed doses should come from your prescriber or the leaflet, not a search result.

What you should not do is double up: taking two doses in quick succession does not compensate for a missed one and increases the chance of gastrointestinal side effects. If you are ever uncertain whether to inject on a different day or skip the week, contact your clinical team. At nume, prescribers are available seven days a week for exactly this kind of aftercare question. You can reach the team through the contact page.

One thing worth knowing for planning purposes: if you are considering surgery, anaesthetists need to know you are on a GLP-1 medicine. Tell your surgical team in advance so they can advise on pausing treatment, this is an NHS England recommendation, not an edge case.

Dose increases and what drives the decision

Titration (moving up through the doses) happens when your prescriber is satisfied you have tolerated the current level. There is no universal finish line for everyone; some people find 7.5 mg or 10 mg is where they stay long-term because it works well and side effects are manageable. Others work through to 12.5 mg or 15 mg under clinical guidance.

NICE's appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. Your prescriber will track this with you. At nume, every repeat order goes through a fresh clinical review (a real clinician reads your update, not a queued algorithm) so the dose question is revisited each cycle rather than left to drift.

If you would like to understand how the cost of treatment sits across the dose schedule, the Mounjaro pricing page breaks that down honestly. And if you have questions about how often you take Mounjaro and what that looks like across the full course of treatment, that page covers the nuance alongside a closer look at the Mounjaro dosing schedule and how frequently each step tends to move, and our page on how often you use Mounjaro goes into further detail on building the weekly injection into your routine.

Side effects by phase: what the weekly rhythm tends to look like

The GI effects people read about (nausea, loose stools, reflux, reduced appetite) tend to cluster around the first couple of weeks on a new dose level, not throughout the entire weekly cycle. Many people find the few days after the injection are the most noticeable, with symptoms easing toward the end of the week. That pattern often improves considerably once the body has had a full four-week cycle to adjust.

Side effects that warrant prompt attention include severe or persistent stomach pain that radiates to the back, this should be assessed medically without delay, as the MHRA highlighted acute pancreatitis as a known, though infrequent, risk for GLP-1 medicines. Dehydration from significant vomiting or diarrhoea, injection-site reactions that worsen, and any signs of an allergic response also need medical review rather than waiting until the next scheduled check-in.

Reporting suspected side effects (or a pen that looks or smells wrong) can be done directly through the MHRA Yellow Card scheme. It takes a few minutes and genuinely helps the regulator track real-world safety signals. Our FAQs page answers several questions about managing the early weeks on Mounjaro if you want more practical detail.